Articles Published in 2011

Anavex successfully completes phase I Alzheimer's trial

Monday, November 14, 2011 11:17 AM

Anavex Life Sciences has successfully completed its phase I single ascending dose (SAD) clinical trial of ANAVEX 2-73, the company's lead drug candidate for the treatment of Alzheimer's Disease.  ANAVEX 2-73 is the first of a new class of oral drugs being studied to potentially treat AD through disease modification rather than focusing only on symptomatic improvement.

More... »

Pantarhei Bioscience discovers ovarian cancer treatment

Monday, November 14, 2011 10:52 AM

Pantarhei Bioscience, a pharmaceutical company focusing on the development of  treatments in the fields of women’s health and endocrine cancer, has reported the results of an innovative treatment strategy for ovarian cancer. 

More... »

Pacific Urology, Diablo Valley Oncology merge launching multi-specialty practice

Monday, November 14, 2011 10:07 AM

Two private specialty medical practices have agreed to merge forming the area's first multi-specialty practice in oncology and urology as a hedge against mounting business challenges in a rapidly changing healthcare landscape.

More... »

U.K.’s MRN brings its home services for patients to U.S. market, predicting big growth in clinical trials use

Monday, November 14, 2011 08:02 AM

U.K.-based Medical Research Network (MRN), a five-year-old company that arranges for clinical trial participants to be seen in their homes rather than requiring them to travel to an investigative site, recently announced it is establishing a presence in the U.S. via a new office in Raleigh, N.C. 

More... »

Benchmark, poised for growth, adds two vice presidents

Monday, November 14, 2011 08:00 AM

Benchmark Research, an Austin, Texas-based group of six investigative sites, is making some strategic hires as it positions itself for growth.

More... »

ACORN Research collaborates with AdeptBio

Friday, November 11, 2011 11:23 AM

ACORN Research has expanded its research footprint to support advances in personalized medicine and translational research, by offering high-quality biospecimens coupled with premium data to industry and academic research through its partnership with AdeptBio.

More... »

Otsuka, H. Lundbeck partner to develop innovative medicines

Friday, November 11, 2011 11:02 AM

Otsuka Pharmaceutical and H. Lundbeck have entered into a long-term agreement for the development and commercialization of up to five innovative psychiatric and neuroscience products worldwide.

More... »

Avaxia raises $2.2 million in Series A financing

Friday, November 11, 2011 10:44 AM

Avaxia Biologics, a privately-held biotech company, has completed its first close of $2.2 million of a Series A angel-led financing. Cherrystone Angels of Providence, Rhode Island led the round, with participation from Boston Harbor Angels and other undisclosed individuals. Mr. Robert Manning, the co-Chairman of Cherrystone Angels, will join the Avaxia board.

More... »

Springer to acquire Wolters Kluwer's MPS division

Thursday, November 10, 2011 02:07 PM

Springer Science+Business Media has reached an agreement with Wolters Kluwer to acquire the Pharma Marketing and Publishing Services division (MPS) for its Springer Healthcare unit. MPS is one of the five largest global providers of strategic marketing, publishing and business intelligence products and services to the pharmaceutical industry, as well as to medical libraries and academic and research institutions.

More... »

Signum, GlaxoSmithKline ink research agreement

Thursday, November 10, 2011 10:09 AM

More... »